ClinConnect ClinConnect Logo
Search / Trial NCT02088528

The Ghana Primary Tube Versus Trabeculectomy Study

Launched by TEMA CHRISTIAN EYE CENTER · Mar 14, 2014

Trial Information

Current as of October 21, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 to 85 years, inclusive
  • Open angle glaucoma. Including primary open angle glaucoma, pseudoexfoliative and pigmentary glaucoma
  • Intraocular pressure 18 - 40 mmHg on maximal tolerated or maximal affordable medical therapy
  • Informed consent given and consent form signed.
  • Exclusion Criteria:
  • Unwilling or unable to give consent, unwilling to accept randomisation, or unable to return for scheduled protocol visits
  • Pregnant or nursing women
  • No light perception vision
  • Previous incisional intraocular surgery, other than uncomplicated clear corneal cataract surgery
  • Previous ocular laser in study eye
  • Iris neovascularisation or proliferative retinopathy
  • Primary angle closure or primary angle closure glaucoma
  • Iridocorneal endothelial syndrome or anterior segment dysgenesis
  • Epithelial or fibrous downgrowth
  • Aphakia
  • Chronic or recurrent uveitis
  • Steroid-induced glaucoma
  • Severe posterior blepharitis
  • Unwilling to discontinue contact lens use after surgery
  • Previous cyclodestructive procedure
  • Glaucoma secondary to penetrating keratoplasty, trauma, retinal disease/surgery or neovascular disease
  • Conjunctival scarring from prior ocular surgery, trauma or cicatrizing disease precluding a superior trabeculectomy
  • Need for glaucoma surgery combined with other ocular procedures (i.e. cataract surgery, penetrating keratoplasty, or retinal surgery) or anticipated need for urgent additional ocular surgery

About Tema Christian Eye Center

Tema Christian Eye Center is a leading healthcare institution dedicated to advancing ophthalmic care through innovative research and clinical trials. With a commitment to enhancing vision health in the community, the center focuses on the development and evaluation of cutting-edge therapies and interventions for various eye conditions. By collaborating with expert researchers and healthcare professionals, Tema Christian Eye Center aims to contribute to the global understanding of eye diseases and improve patient outcomes through evidence-based practices. Their rigorous approach to clinical trials ensures the highest standards of safety and efficacy in the pursuit of better vision for all.

Locations

Tema, Ghana

Patients applied

0 patients applied

Trial Officials

Alexander Spratt, MBBCh FRCOphth

Principal Investigator

Tema Christian Eye Center

Keith Barton, MBBCh MD FRCP FRCOphth

Study Chair

Moorfields Eye Hospital NHS Foundation Trust

Donald L Budenz, MD MPH

Study Chair

University of North Carolina, Chapel Hill

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials